Abstract
Activating β-catenin mutations with aberrant cytoplasmic and nuclear protein accumulation are hallmarks of adamantinomatous craniopharyngiomas (adaCP). These tumours tend to be associated with unfavourable and occasionally disastrous sequelae, as they invade adjacent brain structures such as the hypothalamus. The peculiar digitate growth pattern does not always allow gross surgical removal often leading to recurrence. The tips of invading adaCP epithelium harbour cell clusters with nuclear β-catenin accumulations, suggesting an influence of β-catenin-dependent signal transduction on the tumour migratory capacity. This hypothesis was tested by suppressing β-catenin expression in six primary human adaCP cell cultures using small interfering RNA (siRNA) directed against the β-catenin gene (CTNNB1). Tumour cell migration was significantly reduced in Boyden chamber and wound-healing experiments following siRNA treatment. We further showed that fascin, a target gene of β-catenin TCF signalling in colorectal cancer cells and a key component of filopodia, is also involved in this process. β-Catenin accumulating tumour cells co-express fascin and fascin mRNA levels can be significantly down-regulated in adaCP cultures treated with CTNNB1 siRNA. Furthermore, migration experiments showed a significantly lower cell motility of adaCP tumour cells in vitro when transfected with fascin siRNA. This suggests that activated Wnt-signalling serves as a promoter of the epithelial migration machinery by regulating target molecules such as fascin in adaCP tumour cells.
Similar content being viewed by others
References
Behrens J, Jerchow BA, Wurtele M et al (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599
Behrens J, Lustig B (2004) The Wnt connection to tumorigenesis. Int J Dev Biol 48:477–487
Behrens J, von Kries JP, Kuhl M et al (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642
Buslei R, Holsken A, Hofmann B et al (2007) Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol 113:585–590
Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol (Berl) 109:589–597
Chen SF, Lin CY, Chang YC et al (2009) Effects of small interfering RNAs targeting Fascin on gene expression in oral cancer cells. J Oral Pathol Med 38:722–730
Darnel AD, Behmoaram E, Vollmer RT et al (2009) Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res 15:1376–1383
Demir R, Dimmler A, Naschberger E et al (2009) Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. Exp Mol Pathol 87:109–116
Fahlbusch R, Hofmann BM (2008) Surgical management of giant craniopharyngiomas. Acta Neurochir (Wien) 150:1213–1226
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–250
Gao X, Wu DH (2008) Fascin expression in human epithelial tumors and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 28:953–955
Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphaned J Rare Dis 2:18
Green H, Kehinde O, Thomas J (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Accad Sci USA 76:5665–5668
Growthy A, Hashizume R, Ji H et al (2000) C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19:4864–4875
Hashimoto Y, Skacel M, Adams JC (2005) Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37:1787–1804
Henderson BR (2000) Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2:653–660
Hofmann BM, Kreutzer J, Saeger W et al (2006) Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 30:1595–1603
Holsken A, Kreutzer J, Hofmann BM et al (2009) Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 19:357–364
Hulsken J, Birchmeier W, Behrens J (1994) E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 127:2061–2069
Iguchi T, Aishima S, Umeda K et al (2009) Fascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol 100:575–579
Jamora C, DasGupta R, Kocieniewski P, Fuchs E (2003) Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422:317–322
Karavitaki N, Brufani C, Warner JT et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409
Karavitaki N, Cudlip S, Adams CB, Wass JA (2006) Craniopharyngiomas. Endocr Rev 27:371–397
Kato K, Nakatani Y, Kanno H et al (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203:814–821
Mattila PK, Lappalainen P (2008) Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 9:446–454
Muller T, Bain G, Wang X, Papkoff J (2002) Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res 280:119–133
Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483–1487
Oikonomou E, Barreto DC, Soares B, De Marco L, Buchfelder M, Adams EF (2005) Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol 73:205–209
Okada K, Shimura T, Asakawa K et al (2007) Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. Hepatogastroenterology 54:17–21
Orsulic S, Huber O, Aberle H, Arnold S, Kemler R (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112(Pt 8):1237–1245
Parsons M, Adams JC (2008) Rac regulates the interaction of fascin with protein kinase C in cell migration. J Cell Sci 121:2805–2813
Pereira AM, Schmid EM, Schutte PJ et al (2005) High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 62:197–204
Sartoretti-Schefer S, Wichmann W, Aguzzi A, Valavanis A (1997) MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. Am J Neuroradiol 18:77–87
Sekine S, Shibata T, Kokubu A et al (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997–2001
Sekine S, Takata T, Shibata T et al (2004) Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology 45:573–579
Tao YS, Edwards RA, Tubb B, Wang S, Bryan J, McCrea PD (1996) Beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol 134:1271–1281
Viac J, Reano A, Brochier J, Staquet MJ, Thivolet J (1983) Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol 81:351–354
Vignjevic D, Schoumacher M, Gavert N et al (2007) Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67:6844–6853
Wong NA, Pignatelli M (2002) Beta-catenin—a linchpin in colorectal carcinogenesis? Am J Pathol 160:389–401
Yamashiro S, Yamakita Y, Ono S, Matsumura F (1998) Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 9:993–1006
Yildiz L, Kefeli M, Aydin O, Kandemir B (2009) Fascin expression in melanocytic lesions of the skin. Eur J Dermatol 19:445–450
Acknowledgments
We thank Verena Schmidt for her excellent technical assistance. Additionally, we are indebted to Nadine Schmiedel, Diana Maron, Silke Sterner and Katharina Porsche for performing immunohistochemical stainings and Jeremy Wiles for proof-reading the manuscript. This work was supported by the ELAN fund (08.09.08.1) of the University Hospital Erlangen (to AH and RB).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hölsken, A., Buchfelder, M., Fahlbusch, R. et al. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol 119, 631–639 (2010). https://doi.org/10.1007/s00401-010-0642-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-010-0642-9